DREYLİNG, M. Et Al. 2017. Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1. ASH 2017 .

DREYLİNG, M., PANAYİOTİDİS, P., MİKLOS, E., GEORGE, F., MİLLOCA, L., NAGLER, A., ... ÖZCAN, M.(2017). Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 . ASH 2017

DREYLİNG, MARTİN Et Al. "Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1," ASH 2017, 2017

DREYLİNG, MARTİN Et Al. "Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1." ASH 2017 , 2017

DREYLİNG, M. Et Al. (2017) . "Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1." ASH 2017 .

@conferencepaper{conferencepaper, author={MARTİN DREYLİNG Et Al. }, title={Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1}, congress name={ASH 2017}, city={}, country={}, year={2017}}